Inter Pharma PCL (BKK:IP)

Market Cap	2.63B +43.7%
Revenue (ttm)	2.17B +20.3%
Net Income	111.34M +887.9%
EPS	0.18 +888.0%
Shares Out	605.34M
PE Ratio	23.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	183,513
Average Volume	212,990
Open	4.340
Previous Close	4.320
Day's Range	4.300 - 4.400
52-Week Range	2.020 - 4.700
Beta	0.44
RSI	41.67
Earnings Date	Feb 27, 2026

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 64
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.